Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: Alzheimer's disease,treatment of (Click to remove) Lecanemab in Early Alzheimers Disease NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023 Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial JAMA 330:512-517, 510, Sims,J.R.,et al, 2023 Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment Neurol 101:1079-1080, Bonami,S.,et al, 2023 Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Aducanumab: What About the Patient? Ann Neurol 90:334-335, Petersen, R.C., 2021 Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road? NEJM 370:377-378, Karran, E. & Hardy, J., 2014 Showing articles 0 to 6 of 6